SEPTInvestingStart Free

ARCT SCHEDULE 13G/A: SEC filing

Federated Hermes, Inc. and affiliated entities

Filed with the SEC on · accession 0001623632-26-001546

ARCT filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 7, 2026. Federated Hermes, Inc. and affiliated entities filed an amended Schedule 13G disclosing their beneficial ownership position in Arcturus Therapeutics Holdings Inc. as passive investors. The stock moved -1.8% by the first close after the filing.

Summary of the filing

Federated Hermes, Inc. and affiliated entities filed an amended Schedule 13G disclosing their beneficial ownership position in Arcturus Therapeutics Holdings Inc. as passive investors. The filing is a routine amendment with no indication of activist intent.

For details, click here →

Key details

Issuer of reported securitiesArcturus Therapeutics Holdings Inc.
Parent holding company / reporting personFederated Hermes, Inc.
Investment adviser / reporting personFederated Global Investment Management Corp.
Intermediate holding company / reporting personFII Holdings, Inc.
Trust holding voting stock of parent / reporting personVoting Shares Irrevocable Trust
Registered investment company / reporting personFederated Hermes Equity Funds
Registered investment company / reporting personFederated Hermes Insurance Series
Trustee, voting shares irrevocable trustThomas R. Donahue
Trustee, voting shares irrevocable trustAnn C. Donahue
Trustee, voting shares irrevocable trustJ. Christopher Donahue

How ARCT stock reacted

Close before

$13.00

Oct 6, 2026

First close after

-1.81%

$12.77

5 trading days

-7.46%

$12.03

Since filing

-28.00%

$9.36

✦ Ask GOAX AI about this filing — what it means for ARCT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ARCT?

Click here

Frequently asked questions

What did ARCT file with the SEC on Oct 7, 2026?

ARCT filed a SCHEDULE 13G/A (SEC filing). Federated Hermes, Inc. and affiliated entities filed an amended Schedule 13G disclosing their beneficial ownership position in Arcturus Therapeutics Holdings Inc. as passive investors. The filing is a routine amendment with no indication of activist intent.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ARCT stock react to this filing?

ARCT closed at $13.00 before the filing and $12.77 on Oct 7, 2026 (-1.81%). Five trading days later: $12.03 (-7.46%).

Other ARCT SEC filings

Get alerts when ARCT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
ARCT overviewARCT analysisARCT newsLatest SEC filings